Premature Coronary Atherosclerosis in Scleroderma
1 other identifier
observational
28
1 country
1
Brief Summary
The purpose of this trial is to study the proportion of scleroderma patients who suffer from asymptomatic coronary atherosclerosis compared to healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2006
CompletedFirst Posted
Study publicly available on registry
September 6, 2006
CompletedStudy Start
First participant enrolled
October 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedSeptember 16, 2010
September 1, 2010
3.8 years
September 5, 2006
September 15, 2010
Conditions
Keywords
Eligibility Criteria
scleroderma patients
You may qualify if:
- Age \>= 18 years.
- Fulfillment of the American College of Rheumatology (ACR) criteria for the classification of scleroderma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tuen Mun Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
CC Mok, MD FRCP
Tuen Mun Hospital Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
September 5, 2006
First Posted
September 6, 2006
Study Start
October 1, 2006
Primary Completion
July 1, 2010
Study Completion
July 1, 2010
Last Updated
September 16, 2010
Record last verified: 2010-09